Psoriasis Research Today is a free monthly online journal that collates and summarizes the latest research about Psoriasis, including details on treatment, prevention, medication, causes.

Volume 2 (2005), Issue 6 (June)

1. Incidental detection of S. pyogenes-DNA in psoriatic skin by PCR.
   Arch Dermatol Res, 296(12): 573-6. [Abstract] [Full-text]
2. A two-compound product containing calcipotriol and betamethasone dipropionate provides rapid, effective treatment of psoriasis vulgaris regardless of baseline disease severity.
   Dermatology, 210(4): 294-9. [Abstract] [Full-text]
3. Two decades experience of the Psoriasis Disability Index.
   Dermatology, 210(4): 261-8. [Abstract] [Full-text]
4. Development of the US PSORIQoL: a psoriasis-specific measure of quality of life.
   Int J Dermatol, 44(6): 462-9. [Abstract] [Full-text]
5. Exacerbation of psoriasis due to peginterferon alpha-2b plus ribavirin treatment of chronic active hepatitis C.
   Chemotherapy, 51(2): 167-9. [Abstract] [Full-text]
6. Functional MASP2 single nucleotide polymorphism plays no role in psoriasis.
   Br J Dermatol, 152(6): 1313-5. [Abstract] [Full-text]
7. A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction.
   Br J Dermatol, 152(6): 1304-12. [Abstract] [Full-text]
8. Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life.
   Br J Dermatol, 152(6): 1256-62. [Abstract] [Full-text]
9. Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial.
   Br J Dermatol, 152(6): 1219-27. [Abstract] [Full-text]
10. Activation of dendritic antigen-presenting cells expressing common heat shock protein receptor CD91 during induction of psoriasis.
    Br J Dermatol, 152(6): 1211-8. [Abstract] [Full-text]
11. Dual wavelength (532 and 633 nm) laser Doppler imaging of plaque psoriasis.
    Br J Dermatol, 152(6): 1182-6. [Abstract] [Full-text]
12. Psoriasis: dysregulation of innate immunity.
    Br J Dermatol, 152(6): 1098-107. [Abstract] [Full-text]
13. Corneodesmosin (CDSN) gene association with psoriasis vulgaris in Caucasian but not in Japanese populations.
    Clin Exp Dermatol, 30(4): 414-8. [Abstract] [Full-text]
14. Electrical measurement of moisturizing effect on skin hydration and barrier function in psoriasis patients.
    Clin Exp Dermatol, 30(4): 409-13. [Abstract] [Full-text]
15. Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin.
    J Invest Dermatol, 124(6): 1284-92. [Abstract] [Full-text]
16. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept.
    J Invest Dermatol, 124(6): 1275-83. [Abstract] [Full-text]
17. Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases.
    J Invest Dermatol, 124(6): 1225-33. [Abstract] [Full-text]
18. Genetics of psoriasis in Iceland: evidence for linkage of subphenotypes to distinct Loci.
    J Invest Dermatol, 124(6): 1177-85. [Abstract] [Full-text]
19. Amphiregulin causes functional downregulation of adherens junctions in psoriasis.
    J Invest Dermatol, 124(6): 1134-40. [Abstract] [Full-text]
20. Hip joint disease in psoriatic arthritis: risk factors and natural history.
    Ann Rheum Dis, 64(7): 1068-70. [Abstract] [Full-text]
21. Identification and characterization of a novel, psoriasis susceptibility-related noncoding RNA gene, PRINS.
    J Biol Chem, 280(25): 24159-67. [Abstract] [Full-text]
22. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study.
    J Invest Dermatol, 125(1): 61-7. [Abstract] [Full-text]

© 2004-2008 Psoriasis Research Today. All Rights Reserved.